Our results demonstrate that ERK1/2 activation is sufficient to promote proliferation and cell survival in the lumens of mammary epithelial acini, which are characteristic behaviors required for recurrent tumor growth after lumpectomy. Here, MAPK3 is linked to neoplasm.